Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age (vol 35, pg 809, 2021)
LEUKEMIA（2021）
关键词
Myeloma,Randomized controlled trials,Stem-cell research,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要